Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.

Ito S, Nagoshi T, Minai K, Kashiwagi Y, Sekiyama H, Yoshii A, Kimura H, Inoue Y, Ogawa K, Tanaka TD, Ogawa T, Kawai M, Yoshimura M.

PLoS One. 2017 Apr 21;12(4):e0176435. doi: 10.1371/journal.pone.0176435. eCollection 2017.

2.

Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.

Kim WY, Baek MS, Kim YS, Seo J, Huh JW, Lim CM, Koh Y, Hong SB.

J Thorac Dis. 2016 Dec;8(12):3648-3657. doi: 10.21037/jtd.2016.12.10.

3.

The Worsening Profile of Alcoholic Hepatitis in the United States.

Nguyen TA, DeShazo JP, Thacker LR, Puri P, Sanyal AJ.

Alcohol Clin Exp Res. 2016 Jun;40(6):1295-303. doi: 10.1111/acer.13069. Epub 2016 May 5.

4.

A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study,,.

Ray M, Ruthazer R, Beshansky JR, Kent DM, Mukherjee JT, Alkofide H, Selker HP.

Int J Cardiol Heart Vasc. 2015 Dec 1;9:37-42. doi: 10.1016/j.ijcha.2015.07.001. Epub 2015 Aug 27.

5.

Effects of acute hyperglycaemia on cardiovascular homeostasis: does a spoonful of sugar make the flow-mediated dilatation go down?

Horowitz JD, Chong CR, Ngo DT, Sverdlov AL.

J Thorac Dis. 2015 Dec;7(12):E607-11. doi: 10.3978/j.issn.2072-1439.2015.12.40. No abstract available.

6.

C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes.

Alkofide H, Huggins GS, Beshansky JR, Ruthazer R, Peter I, Ray M, Mukherjee JT, Selker HP.

BMC Cardiovasc Disord. 2015 Dec 3;15:163. doi: 10.1186/s12872-015-0153-7.

7.

Data monitoring committees for pragmatic clinical trials.

Ellenberg SS, Culbertson R, Gillen DL, Goodman S, Schrandt S, Zirkle M.

Clin Trials. 2015 Oct;12(5):530-6. doi: 10.1177/1740774515597697. Epub 2015 Sep 15.

8.

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study.

Nusca A, Lauria Pantano A, Melfi R, Proscia C, Maddaloni E, Contuzzi R, Mangiacapra F, Palermo A, Manfrini S, Pozzilli P, Di Sciascio G.

J Diabetes Res. 2015;2015:250201. doi: 10.1155/2015/250201. Epub 2015 Jul 26.

9.

Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.

McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, Dutka DP.

Cardiovasc Diabetol. 2015 Aug 8;14:102. doi: 10.1186/s12933-015-0259-3.

10.

Guidelines for Perioperative Management of the Diabetic Patient.

Sudhakaran S, Surani SR.

Surg Res Pract. 2015;2015:284063. doi: 10.1155/2015/284063. Epub 2015 May 19. Review.

11.

Glucose-insulin-potassium solution protects ventricular myocytes of neonatal rat in an in vitro coverslip ischemia/reperfusion model.

Chun WJ, Nah DY, Bae JH, Chung JW, Lee H, Moon IS.

Korean Circ J. 2015 May;45(3):234-41. doi: 10.4070/kcj.2015.45.3.234. Epub 2015 May 27.

12.

Admission glucose and risk of early death in non-diabetic patients with ST-segment elevation myocardial infarction: a meta-analysis.

Zhao CJ, Hao ZX, Liu R, Liu Y.

Med Sci Monit. 2015 May 14;21:1387-94. doi: 10.12659/MSM.894249.

13.

Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction.

van der Horst IC, Timmer JR, Ottervanger JP, Bilo HJ, Miedema K, Gans RO, de Boer MJ, Vogelzang M, Nijsten MW, Zijlstra F.

Neth Heart J. 2006 Mar;14(3):89-94.

14.

Refractory hyperglycaemia induced by glucose-insulin-potassium infusion in acute myocardial infarction.

Vogelzang M, Svilaas T, van der Horst IC, Nijsten MW, Zijlstra F.

Neth Heart J. 2006 Feb;14(2):46-48.

15.

A quantitative analysis of the effect of glucose-insulin-potassium in acute myocardial infarction.

Rasoul S, Svilaas T, Ottervanger JP, Timmer JR, van 't Hof AW, Zijlstra F.

Neth Heart J. 2006 Jan;14(1):19-23.

16.

GIK in acute myocardial infarction: lessons from CREATE-ECLA, GIPS II and DIGAMI 2.

van der Horst IC, Zijlstra F.

Neth Heart J. 2005 Aug;13(7-8):251-253. No abstract available.

17.

Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials.

Jin PY, Zhang HS, Guo XY, Liang WF, Han QF.

BMC Cardiovasc Disord. 2014 Nov 25;14:169. doi: 10.1186/1471-2261-14-169. Review.

18.

Postconditioning signalling in the heart: mechanisms and translatability.

Bice JS, Baxter GF.

Br J Pharmacol. 2015 Apr;172(8):1933-46. doi: 10.1111/bph.12976. Epub 2014 Dec 15. Review.

19.

The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.

Inserte J, Garcia-Dorado D.

Br J Pharmacol. 2015 Apr;172(8):1996-2009. doi: 10.1111/bph.12959. Epub 2015 Mar 16. Review.

20.

Remote conditioning the heart overview: translatability and mechanism.

Schmidt MR, Redington A, B√łtker HE.

Br J Pharmacol. 2015 Apr;172(8):1947-60. doi: 10.1111/bph.12933. Epub 2014 Dec 15. Review.

Supplemental Content

Support Center